MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer.

Oncotarget · 2017 · PMC5617465 · PMID 28977905

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

For the combination of MOC31PE and cisplatin, there was a nonsignificant trend towards reduced viability.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.